Tracking Resistance to Artemisinin Collaboration II

The second iteration of the TRAC project, known as TRAC II, will not only monitor for the further extension or emergence of drug resistance, but will also investigate the safety, tolerability and efficacy of Triple Artemisinin-based Combination Therapies (TACTs) – the first of its kind. In areas with failing ACTs, the aim of TACTs is restoring antimalarial efficacy, whereas in areas where ACTs still work or artemisinin resistance has not yet arrived, it has the potential to delay the emergence of drug resistance.

LSHTM staff: Shunmay Yeung
Funding: DFID
Collaborators: Mahidol Oxford Tropical Medicine Research Unit
Website

Back